Andrea K. Jacobs

Zurich, ZH, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanoma.

Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanoma.

Journal: Nature medicine
Published: August 01, 2025

A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy.

A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy.

Journal: Nature communications
Published: March 09, 2025

Standardization of Suspension and Imaging Mass Cytometry Single-Cell Readouts for Clinical Decision Making.

Standardization of Suspension and Imaging Mass Cytometry Single-Cell Readouts for Clinical Decision Making.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: August 08, 2024

Feasibility of multiomics tumor profiling for guiding treatment of melanoma.

Feasibility of multiomics tumor profiling for guiding treatment of melanoma.

Journal: Nature medicine
Published: July 09, 2024

Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia.

Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia.

Journal: Nature communications
Published: March 08, 2024

Single-cell proteomics defines the cellular heterogeneity of localized prostate cancer.

Single-cell proteomics defines the cellular heterogeneity of localized prostate cancer.

Journal: Cell reports. Medicine
Published: August 30, 2021

Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia.

Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia.

Journal: Nature cancer
Published: August 23, 2021

Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-controlled, randomized, phase II study.

Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-controlled, randomized, phase II study.

Journal: ESMO open
Published: July 01, 2021

A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck - the RESGEX study.

A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck - the RESGEX study.

Journal: ESMO open
Published: April 19, 2021

Mass cytometric and transcriptomic profiling of epithelial-mesenchymal transitions in human mammary cell lines.

Mass cytometric and transcriptomic profiling of epithelial-mesenchymal transitions in human mammary cell lines.

Journal: Scientific data
Published: March 24, 2021

The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support.

The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support.

Journal: Cancer cell
Published: January 22, 2021

An R-based reproducible and user-friendly preprocessing pipeline for CyTOF data.

An R-based reproducible and user-friendly preprocessing pipeline for CyTOF data.

Journal: F1000Research
Published: October 22, 2020
Showing 1-12 of 31

Last Updated: 09/26/2026